- Home
- BRW vs OSUR Comparison
BRW vs OSUR Comparison
Compare BRW & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRW
- OSUR
- Stock Information
- Founded
- BRW 1987
- OSUR 2000
- Country
- BRW United States
- OSUR United States
- Employees
- BRW N/A
- OSUR N/A
- Industry
- BRW Trusts Except Educational Religious and Charitable
- OSUR Medical/Dental Instruments
- Sector
- BRW Finance
- OSUR Health Care
- Exchange
- BRW Nasdaq
- OSUR Nasdaq
- Market Cap
- BRW 319.4M
- OSUR 319.9M
- IPO Year
- BRW N/A
- OSUR 1986
- Fundamental
- Price
- BRW $7.54
- OSUR $3.85
- Analyst Decision
- BRW
- OSUR Buy
- Analyst Count
- BRW 0
- OSUR 3
- Target Price
- BRW N/A
- OSUR $6.67
- AVG Volume (30 Days)
- BRW 222.1K
- OSUR 568.9K
- Earning Date
- BRW 01-01-0001
- OSUR 11-06-2024
- Dividend Yield
- BRW 15.59%
- OSUR N/A
- EPS Growth
- BRW N/A
- OSUR N/A
- EPS
- BRW N/A
- OSUR 0.15
- Revenue
- BRW N/A
- OSUR $224,263,000.00
- Revenue This Year
- BRW N/A
- OSUR N/A
- Revenue Next Year
- BRW N/A
- OSUR N/A
- P/E Ratio
- BRW N/A
- OSUR $25.49
- Revenue Growth
- BRW N/A
- OSUR N/A
- 52 Week Low
- BRW $7.15
- OSUR $3.85
- 52 Week High
- BRW $8.30
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- BRW 59.36
- OSUR 35.29
- Support Level
- BRW $7.50
- OSUR $4.15
- Resistance Level
- BRW $7.56
- OSUR $4.37
- Average True Range (ATR)
- BRW 0.06
- OSUR 0.17
- MACD
- BRW 0.00
- OSUR -0.03
- Stochastic Oscillator
- BRW 81.25
- OSUR 0.66
About BRW Saba Capital Income & Opportunities Fund SBI
Saba Capital Income & Opportunities Fund t is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.